


Ask a doctor about a prescription for MEDIKINET 20 mg PROLONGED-RELEASE HARD CAPSULES
Package Leaflet: Information for the User
Medikinet 20 mg prolonged-release hard capsules
methylphenidate hydrochloride
This medicine is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.
Read all of this leaflet carefully before you or your child start taking this medicine, because it contains important information for you.
|
Contents of the pack
What is it used for
Medikinet is used to treat “attention deficit hyperactivity disorder” (ADHD).
Medikinet is not indicated for the treatment of ADHD in children under 6 years of age.
How it works
Medikinet improves the activity of certain parts of the brain that are underactive. The medicine may help improve attention and concentration levels and reduce impulsive behavior.
The medicine is given as part of a comprehensive treatment program, which usually includes psychological, educational, and social therapy.
Treatment with Medikinet should only be initiated by a doctor specializing in the treatment of ADHD, such as a pediatrician, child and adolescent psychiatrist, or psychiatrist, and under their supervision. This doctor will perform a thorough medical examination. If you, as an adult, have not received this type of treatment before, the doctor will perform tests to confirm that you have had ADHD since childhood. Although ADHD has no cure, it can be controlled using comprehensive treatment programs.
About ADHD
Children and adolescents with ADHD have:
It is not their fault that they cannot do these things.
Patient may present different degrees of ADHD with symptoms such as:
Some of the external signs are:
ADHD does not affect the child's or adolescent's intelligence.
Do not take Medikinet if you or your child
Do not take methylphenidate if you or your child have any of the above. If you are not sure, consult your doctor or pharmacist before taking methylphenidate. This is because methylphenidate may worsen these problems.
Warnings and precautions
Consult your doctor before starting to take Medikinet if you or your child
Tell your doctor or pharmacist if you or your child have any of the above before starting treatment. Methylphenidate may worsen these problems. Your doctor will want to monitor how the medicine affects you or your child.
During treatment, children and adolescents may unexpectedly experience prolonged erections. Erections can be painful and occur at any time. It is essential to contact the doctor immediately if the erection lasts more than 2 hours, especially if it is painful.
Checks that your doctor will make before you or your child start taking methylphenidate
To decide if methylphenidate is the right medicine for you or your child, your doctor will check the following with you:
Your doctor will explain specifically if you or your child are at risk of experiencing mood changes (from being manic to being depressed, also known as bipolar disorder). Your doctor will also check your or your child's mental health history and check if any family members have a history of suicide, bipolar disorder, or depression.
It is essential that you provide all the information you can. This will help your doctor decide if methylphenidate is the right medicine for you or your child. Your doctor may decide that you or your child need other medical tests before starting to take this medicine. For adult patients starting to take Medikinet, your doctor may refer you to a heart specialist.
Drug tests
This medicine may give positive results in drug tests.
Athletes should be aware that this medicine may produce a positive result in doping tests.
Taking Medikinet with other medicines
Tell your doctor or pharmacist if you or your child are taking, have recently taken, or might take any other medicines.
Do not take methylphenidate if you or your child:
If you or your child are taking other medicines, methylphenidate may affect how they work or cause side effects. Tell your doctor if you or your child are taking medicines for:
Medikinet should not be taken with H2 receptor blockers, proton pump inhibitors, or antacids (medicines to reduce stomach acid secretion or to treat excessive stomach acidity), as they may cause faster release of the total amount of active substance.
If you are unsure whether any of the medicines you or your child are taking are included in the above list, consult your doctor or pharmacist for advice before taking methylphenidate.
Before an operation
Tell your doctor if you or your child are going to have an operation. You should not take methylphenidate on the day of the operation with certain types of anesthetics, as it may cause a sudden increase in blood pressure during the procedure.
Taking methylphenidate with alcohol
Do not drink alcohol while taking this medicine. Alcohol may worsen the side effects of this medicine. Remember that some foods and medicines contain alcohol.
Pregnancy and breastfeeding
Available data do not suggest an increased risk of total congenital anomalies, although a small increased risk of cardiac malformations during use in the first three months of pregnancy cannot be ruled out. Your doctor will provide more information about this risk.
Consult your doctor or pharmacist before using methylphenidate if you or your daughter:
Driving and using machines
You or your child may experience dizziness, drowsiness, problems focusing, or blurred vision, have hallucinations, or other effects on the central nervous system when taking methylphenidate. If this happens, it may be dangerous to perform certain activities, such as driving, operating machinery, riding a bicycle or horse, or climbing trees.
Medikinet contains sucrose
If your doctor has told you that you or your child have an intolerance to some sugars, consult them before taking this medicine.
Medikinet contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially “sodium-free”.
.
Follow your doctor's administration instructions for this medication exactly. If in doubt, consult your doctor or pharmacist again.
Dose
Use in children
The maximum daily dose is 60 mg.
Use in adults
For adults who have taken Medikinet before
For adults who have not taken Medikinet before
The recommended initial dose is 10 mg per day.
Things your doctor will do during your treatment or your child's treatment
Your doctor will perform some tests
How to take
This medication is for oral administration.
Medikinet should be administered to children in the morning with or afterbreakfast.
Medikinet should be administered to adults with or afterbreakfast andlunch.
Medikinet is a controlled-release form of methylphenidate, which releases the medication gradually over a prolonged period. It is very important to take the capsule with or after meals to prolong its action.
The capsules can be swallowed whole with a little water or opened and sprinkled with a small amount (one tablespoon) of apple sauce or yogurt, and taken immediately. Do not store it for future use.
The capsules and their contents should not be crushed or chewed.
If you or your child do not feel better after 1 month of treatment
If you or your child do not feel better after 1 month of treatment, inform your doctor. Your doctor may decide if you or your child need a different treatment.
Long-term treatment
Medikinet does not need to be taken indefinitely. If you or your child take Medikinet for more than a year, your doctor should interrupt treatment at least once a year for a short period. In the case of children, the interruption can be done during school vacations. This allows demonstrating if the medication is still needed.
Improper use of Medikinet
If Medikinet is not used properly, it can cause abnormal behavior. This can also mean that you or your child start to depend on the medication. Inform your doctor if you or your child have ever abused or been dependent on alcohol, prescription medications, or illegal drugs.
This medication has been prescribed to you only and you should not give it to others, even if they have the same symptoms as you.
If you or your child take more Medikinet than you should
In case of overdose or accidental ingestion, call your doctor, the emergency service of the nearest hospital, or the Toxicology Information Service immediately, telephone: 91 562 04 20, indicating the medication and the amount ingested. You may need medical treatment.
The signs of overdose may include: vomiting, agitation, tremors, increased uncontrolled movements, muscle contractions, seizures (sometimes followed by coma), feeling of great happiness, confusion, seeing, feeling, or hearing things that are not real (hallucinations), sweating, flushing, headache, high fever, changes in heartbeats (slow, fast, or irregular), high blood pressure, dilated pupils, and dryness of the nose and mouth, muscle spasms, fever, and darkening of the urine to a reddish-brown color, which could be possible signs of abnormal muscle breakdown (rhabdomyolysis).
.
If you or your child forget to take Medikinet
Do not take a double dose to make up for forgotten doses. If you or your child forget a dose, wait to take the next dose at the scheduled time.
If you or your child stop taking Medikinet
If you or your child suddenly stop taking this medication, the symptoms of ADHD or unwanted effects, such as depression, may reappear. Your doctor may want to gradually reduce the amount of medication you take each day before stopping it completely. Consult your doctor before stopping treatment with Medikinet.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them. Your doctor will inform you about these side effects.
Some side effects can be serious. If you or your child have any of the following side effects, go to your doctor immediately:
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Unknown: frequency cannot be estimated from the available data
If you or your child have any of the above side effects, go to your doctor immediately.
The following are other side effects, and if they become serious, please go to your doctor or pharmacist immediately:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Unknown: frequency cannot be estimated from the available data
Effects on growth
When taken for more than a year, methylphenidate may reduce growth in some children. This affects less than 1 in 10 children.
Reporting of side effects:
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect that is not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the blister pack and on the outer packaging after EXP. The expiration date is the last day of the month indicated.
Do not store above 30°C.
Keep in the original packaging to protect the medication from moisture.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition ofMedikinet
The active ingredient is: methylphenidate hydrochloride.
Each prolonged-release hard capsule contains 20 mg of methylphenidate hydrochloride equivalent to 17.30 mg of methylphenidate.
The other components are:
Capsule Content:
Sugar spheres (contain sucrose and corn starch), methacrylic acid-ethyl acrylate copolymer (1:1), talc, triethyl citrate, polyvinyl alcohol, macrogol 3350, polysorbate 80, sodium hydroxide, sodium lauryl sulfate, simethicone, anhydrous colloidal silica, methylcellulose, sorbic acid, carmine, aluminum lake (E-132).
Capsule Shell:
Gelatin, erythrosine (E-127), titanium dioxide (E-171), sodium lauryl sulfate, purified water, patented blue V (E-131)
Appearance of theProductand Container Content
Capsule body opaque purple / capsule cap opaque purple (15.9 mm) containing white and blue pellets.
Package sizes: Boxes of 20, 24, 27, 28, 30, 36, 45, 48, 50, 54, 60, 63, 90, 96 or 99 prolonged-release hard capsules, packaged in PVC/PVdC aluminum blisters.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
MEDICE Arzneimittel Pütter GmbH & Co. KG
Kuhloweg 37
58638 Iserlohn
Germany
Manufacturer:
MEDICE Arzneimittel Pütter GmbH & Co. KG
Kuhloweg 37
58638 Iserlohn
Germany
Local Representative:
Laboratorios Farmacéuticos ROVI, S.A.
Julián Camarillo, 35
28037 Madrid
This medicinal product is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Germany: Medikinet retard 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Austria: Medikinet retard 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Denmark: Medikinet CR 20 mg
Spain: Medikinet 20 mg prolonged-release hard capsules
Finland: Medikinet CR 20 mg
Iceland: Medikinet CR 20 mg hart hylki með breyttan losunarhraða
Luxembourg: Medikinet retard 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung
Netherlands: Medikinet CR 20 mg capsule met gereguleerde afgifte, hard
Norway: Medikinet 20 mg Kapsel med modifisert frisetting, hard
Poland: Medikinet CR 20 mg
Sweden: Medikinet 20 mg Kapsel med modifierad frisättning, hård
United Kingdom: Medikinet XL 20 mg modified-release capsules hard
(Northern Ireland)
Date of the last revision of this leaflet:May 2025
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of MEDIKINET 20 mg PROLONGED-RELEASE HARD CAPSULES in November, 2025 is around 11.11 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MEDIKINET 20 mg PROLONGED-RELEASE HARD CAPSULES – subject to medical assessment and local rules.